Helicobacter pylori infection is the major risk factor for atrophic gastritis

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 959-962

  Kawaguchi, Hiroyuki ^a   Haruma, Ken ^a   Komoto, Kunihiko ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM DETECTION; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; STOMACH BIOPSY; UPPER GASTROINTESTINAL TRACT;

ADULT; AGING; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; PREVALENCE; RADIOIMMUNOASSAY; RISK FACTORS;

EID: 0029967081     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ihamäki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30- to 34-year biopsy follow-up study. Scand J Gastroenterol 1985;20:485-91.
2. Kimura K. Chronological transition of the fundic pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-92.
3. Tsujii M, Kawano S, Tsuji S, et al. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterology 1993;104:796-801.
4. Borody TJ, Andrews P, Jankiewicz E, et al. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol 1993;88:1266-8.
5. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Modem Pathol 1993;6: 281-9.
6. Katelaris PH, Seow F, Lin BPC, et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993;34:1032-7.
7. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-74.
8. Watanabe C, Haruma K, Sumii K, et al. Serum levels of pepsinogen I and gastrin, and gastric acid secretion in patients with gastric cancer. Gastroenterol Endosc 1992;34:31-8 (in Japanese).
9. Haruma K, Yoshihara M, Sumii K, et al. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 1993;28:633-7.
10. Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
11. Watanabe C, Sumii K, Haruma K, et al. An evaluation of gastric cancer mass survey using serum pepsinogen I and II test in local inhabitants. J Gastroenterol Mass Survey 1992;89:92-7 (in Japanese).
12. Mossi S, Meyer-Wyss B, Renner EL, et al. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers. Gut 1993;34:752-6.
13. Hunter FM, Correa P, Fontham E, et al. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993;38:2081-6.
14. Glassman MS, Dallai S, Berezin SH, et al. Helicobacter pylori-related gastroduodenal disease in children. Diagnostic utility of enzyme-linked immunosorbent assay. Dig Dis Sci 1990;35:993-7.
15. Haruma K, Okamoto S, Sumii K, et al. Helicobacter pylori infection and gastroduodenal disease: A comparison of endoscopic findings, histology, and urease test data. Hiroshima J Med Sci 1992;41:65-70.
16. Loffeld RJLF, Stobberingh E, Arends JW. A review of diagnostic techniques for Helicobacter pylori infection. Dig Dis 1993;11:173-80.
17. Karnes WE, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic gastritis. Gastroenterology 1991;101:167-74.
18. Hirschl AM, Brandstätter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
19. Fischbach W, Wosnik K, Kirchner T, et al. Use of serum specific immunoglobulin antibodies to determine Helicobacter pylori-associated gastritis. Z Gastroenterol 1993;31:429-31.
20. Kuipers EJ, Pen̄a AS, Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31.